glp-1 telehealth crackdown news FDA Issues Warnings Against Illegal Marketing CMS unveils $50 GLP-1 prescriptions

2026: Acceleration and Market Transformation The coming year promises rapid evolution across innovation, policy, and market access

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

We employ variants of the peptides GLP-1 and exendin-4 to explore the interplay between helical propensity near the agonist N-terminus and the ability to bind to and activate the receptor

Learn why increased hunger can happen in early treatment, and what to discuss with your provider.

Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies

Does it have any impact